Korean J Gastroenterol.  2013 Jan;61(1):1-2. 10.4166/kjg.2013.61.1.1.

Antiviral Effect of Entecavir Switching Therapy in Chronic Hepatitis B Patients with Clevudine-associated Myopathy

• Tak WY

• KMID: 1775779
• DOI: http://doi.org/10.4166/kjg.2013.61.1.1

Abstract

No abstract available.

MeSH Terms

Antiviral Agents/*adverse effects
Arabinofuranosyluracil/adverse effects/*analogs & derivatives
Female
Guanine/*analogs & derivatives/therapeutic use
Hepatitis B, Chronic/*drug therapy
Humans
Male
Muscular Diseases/*chemically induced
Antiviral Agents
Arabinofuranosyluracil
Guanine

Reference

References

1. Korean Association for the Study of the Liver. KASL Clinical Practice Guidelines: Management of chronic hepatitis B. Clin Mol Hepatol. 2012; 18:109–162.

2. Yoo BC, Kim JH, Chung YH, et al. Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B. Hepatology. 2007; 45:1172–1178.

3. Yoo BC, Kim JH, Kim TH, et al. Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression. Hepatology. 2007; 46:1041–1048.

4. Zhu Y, Yamamoto T, Cullen J, et al. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol. 2001; 75:311–322.

5. Summers J, Mason WS. Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy. Proc Natl Acad Sci U S A. 2004; 101:638–640.

6. Tak WY, Park SY, Cho CM, et al. Clinical, biochemical, and pathological characteristics of clevudine-associated myopathy. J Hepatol. 2010; 53:261–266.

7. Seok JI, Lee DK, Lee CH, et al. Longterm therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA. Hepatology. 2009; 49:2080–2086.

8. Kim BK, Oh J, Kwon SY, et al. Clevudine myopathy in patients with chronic hepatitis B. J Hepatol. 2009; 51:829–834.

9. Lee JW, Lee YJ, Kim JH, et al. Efficacy of entecavir switching therapy in chronic hepatitis B patients with clevudine-induced myopathy. Korean J Gastroenterol. 2013; 61:30–36.